CI up +2.09% percent right now. $CI High is at 101.17 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
CI up +2.09% percent right now. $CI High is at 101.17 and the Low 98.93 with current volume of 738,197.

Recent News posted below.

CI Cigna Corp Recent Headline News

Alzheimer's Association(R) to Develop E-Learning Program with Cigna Foundation Grant; Online Social Support for People Living in Early Stage
Business Wire - 1 hr 48 mins ago
--Cigna-HealthSpring launches month-long Facebook awareness campaign
CI: 101.40 (+2.41)

Early Glance: Managed Care companies
AP - 2 hrs 29 mins ago
NEW YORK (AP) — Shares of some top managed care companies are up at 10 a.m.:
CI: 101.40 (+2.41), UNH: 94.53 (+0.92), AET: 83.28 (+0.99), HUM: 132.46 (+1.88)

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago CIGNA Is Up 1.9% (CI)
Comtex SmarTrend(R) - Mon Nov 10, 7:58AM CST
When CIGNA (NYSE:CI) reported earnings 11 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $1.82 on sales of $8.6 billion. CIGNA actually reported earnings of $1.95 per share on sales of $8.8 billion, beating EPS estimates by $0.12 and beating revenue estimates by $110.4 million. Shares of CIGNA have climbed from $97.10 to $98.99, representing a gain of 1.9% since the company reported earnings 11 days ago.
CI: 101.40 (+2.41)

3 Things That Can Keep the Wind in Catamaran Corp.'s Sails
Keith Speights, The Motley Fool - Motley Fool - Sat Nov 08, 8:00AM CST
It's been a relatively rough year for Catamaran Corporation so far. Just a couple of weeks ago, the pharmacy benefits manager's stock was down more than 10% and even farther away from the highs seen in 2013. After a strong third-quarter earnings...
CI: 101.40 (+2.41), ESRX: 77.83 (-0.04), CTRX: 47.84 (+0.03), CVS: 89.00 (+0.62)

Final Glance: Managed Care companies
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — Shares of some top managed care companies were down at the close of trading:
CI: 101.40 (+2.41), UNH: 94.53 (+0.92), AET: 83.28 (+0.99), HUM: 132.46 (+1.88)

Midday Glance: Managed Care companies
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — Shares of some top managed care companies are down at 1 p.m.:
CI: 101.40 (+2.41), UNH: 94.53 (+0.92), AET: 83.28 (+0.99), HUM: 132.46 (+1.88)

Shave and a Haircut - and Colorectal Cancer Screenings: Maryland Center for Health Equity and the Cigna Foundation Train Barbers, Stylists as Community Health Advocates
Business Wire - Fri Nov 07, 8:00AM CST
--Barbers and hair stylists - trusted voices in the community - to be trained as health advocates to encourage customers to have screenings
CI: 101.40 (+2.41)

Cigna, BJC HealthCare and Washington University Physicians Collaborate to Launch Cigna Individual and Family Plans in St. Louis
Business Wire - Fri Nov 07, 7:30AM CST
--Affordable, quality care for patients provided by BJC HealthCare and Washington University Physicians
CI: 101.40 (+2.41)

Connecticut State Medical Society-IPA, Inc. and Cigna Launch Statewide Collaborative Care Program that Reaches Small and Mid-Size Medical Practices
Business Wire - Thu Nov 06, 10:00AM CST
--Primary care doctors are rewarded for improving patient health and lowering medical costs
CI: 101.40 (+2.41)

General Mills names David Cordani to its board
M2 - Wed Nov 05, 5:35AM CST
Food company General Mills (NYSE:GIS) revealed on Tuesday the addition of David M. Cordani to its board of directors.
CI: 101.40 (+2.41), GIS: 50.90 (-0.46)

CIGNA Set to Possibly Pullback After Yesterday's Rally of 1.29%
Comtex SmarTrend(R) - Tue Nov 04, 4:25PM CST
CIGNA (NYSE:CI) traded in a range yesterday that spanned from a low of $99.48 to a high of $101.27. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $100.64 on volume of 3.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CI: 101.40 (+2.41)

SmarTrend Watching for Potential Pullback in Shares of CIGNA After 1.29% Gain
Comtex SmarTrend(R) - Tue Nov 04, 4:24PM CST
CIGNA (NYSE:CI) traded in a range yesterday that spanned from a low of $99.48 to a high of $101.27. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $100.64 on volume of 3.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CI: 101.40 (+2.41)

General Mills Elects David Cordani To Its Board Of Directors
PR Newswire - Mon Nov 03, 4:02PM CST
General Mills (NYSE: GIS) today elected David M. Cordani to its board of directors.
CI: 101.40 (+2.41), GIS: 50.90 (-0.46)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Horizons: Future of IVD Contract Manufacturing

Updated Category News Views 117

The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...

Continue Reading
Citi Upgrades AerCap Holdings Price Target to $117 Amid Strong Performance

Updated Category News Views 79

Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...

Continue Reading
LG Energy Solution Reports Strong Q2 2025 Financial Performance

Updated Category News Views 750

LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...

Continue Reading
Genpact Shines as a Leader in Sustainability Recognition

Updated Category News Views 264

Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 344

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading